We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$39.5B
AUM Growth
+$3.42B
Cap. Flow
+$4.94B
Cap. Flow %
12.5%
Top 10 Hldgs %
10.56%
Holding
4,400
New
1,066
Increased
1,336
Reduced
1,179
Closed
749

Sector Composition

Rank Sector Weight
1 Energy 13.03%
2 Healthcare 11.97%
3 Financials 8.32%
4 Utilities 7.31%
5 Consumer Discretionary 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCH
1751
DELISTED
PotlatchDeltic
PCH
$2.38M 0.01%
59,099
+13,973
+31% +$583K
WW
1752
PUT
DELISTED
WW International
WW
$2.38M 0.01%
86,600
-200
-0.2% -$4.57K
FPRX
1753
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.38M 0.01%
202,433
+94,734
+88% +$1.2M
SUPN icon
1754
Supernus Pharmaceuticals
SUPN
$2.59B
$2.37M 0.01%
+272,545
New +$2.46M
ABBV icon
1755
CALL
AbbVie
ABBV
$443B
$2.35M 0.01%
66,100
+62,100
+1,553% +$3.45M
XPO icon
1756
XPO
XPO
$23.5B
$2.35M 0.01%
+180,273
New +$1.97M
SHOR
1757
DELISTED
ShoreTel, Inc.
SHOR
$2.35M 0.01%
352,956
+133,905
+61% +$866K
FLY
1758
DELISTED
Fly Leasing Limited
FLY
$2.35M 0.01%
183,200
-60,659
-25% -$868K
TCPC icon
1759
BlackRock TCP Capital
TCPC
$273M
$2.35M 0.01%
146,015
+73,751
+102% +$1.28M
FWONA icon
1760
Liberty Media Series A
FWONA
$22.5B
$2.33M 0.01%
97,190
-279,253
-74% -$6.86M
IPHI
1761
DELISTED
INPHI CORPORATION
IPHI
$2.33M 0.01%
162,241
+75,107
+86% +$1.09M
SCMP
1762
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$2.33M 0.01%
358,679
+58,860
+20% +$391K
TSL
1763
DELISTED
Trina Solar Limited
TSL
$2.33M 0.01%
193,156
-600,664
-76% -$7.5M
EWJ icon
1764
iShares MSCI Japan ETF
EWJ
$21.9B
$2.33M 0.01%
49,405
+33,757
+216% +$1.61M
BAC icon
1765
Bank of America
BAC
$435B
$2.32M 0.01%
136,239
-2,533,083
-95% -$40.3M
HSTM icon
1766
HealthStream
HSTM
$819M
$2.32M 0.01%
96,758
+68,563
+243% +$1.73M
AER icon
1767
AerCap
AER
$23.7B
$2.32M 0.01%
56,764
-338,524
-86% -$15.4M
CTRA
1768
DELISTED
Coterra Energy
CTRA
$2.32M 0.01%
71,022
-536,993
-88% -$18M
EW icon
1769
CALL
Edwards Lifesciences
EW
$49.6B
$2.32M 0.01%
136,200
+6,000
+5% +$94.7K
RVBD
1770
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$2.31M 0.01%
124,759
+8,062
+7% +$152K
ARRY
1771
DELISTED
Array Biopharma Inc
ARRY
$2.31M 0.01%
647,452
+116,551
+22% +$459K
ROL icon
1772
Rollins
ROL
$18.3B
$2.31M 0.01%
266,156
+170,643
+179% +$1.49M
HUBG icon
1773
HUB Group
HUBG
$2.85B
$2.31M 0.01%
113,756
-97,504
-46% -$2.22M
MDR
1774
DELISTED
McDermott International
MDR
$2.3M 0.01%
134,195
+114,195
+571% +$2.46M
WW
1775
CALL
DELISTED
WW International
WW
$2.3M 0.01%
83,800
-15,000
-15% -$342K

Similar funds

Millennium Management's Q3 2014 Portfolio in Review

As of Q3 2014, Millennium Management held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Millennium Management deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.

By sector, the portfolio is most concentrated in Energy at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.

  • Millennium Management's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
  • Millennium Management added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
  • Millennium Management's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
  • Millennium Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
  • Millennium Management's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
  • Millennium Management opened 1,066 new positions and closed 749 in Q3 2014.
  • Millennium Management's portfolio value rose 9.5% quarter-over-quarter to $39.5B.

Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.